Q4 2024 Quest Diagnostics Inc Earnings Call Transcript
Key Points
- Quest Diagnostics Inc (DGX) delivered impressive revenue growth of nearly 15% in the fourth quarter, including approximately 5% organic growth.
- The company completed eight acquisitions in 2024, including LifeLabs in Canada, expanding its geographic reach and service offerings.
- Investments in automation and AI improved quality, customer experience, and productivity, achieving annual 3% Invigorate savings and productivity targets.
- Quest Diagnostics Inc (DGX) expanded its advanced diagnostics menu, driving double-digit growth in clinical areas such as brain health and advanced cardiometabolic testing.
- The company formed new relationships with health plans, increasing access to more than 90% of in-network lives in the US.
- Weather negatively impacted volume by approximately 50 basis points in the fourth quarter.
- The acquisition of LifeLabs, while contributing to revenue growth, carries a lower revenue per requisition, impacting overall revenue per requisition metrics.
- Quest Diagnostics Inc (DGX) expects hospitals to continue struggling with high wage and supply inflation, which may affect future growth.
- The company anticipates higher interest expenses due to funding acquisitions, representing a $0.50 headwind.
- Quest Diagnostics Inc (DGX) is making significant investments in IT infrastructure and FDA compliance, which may impact short-term profitability.
Welcome to the Quest Diagnostics fourth-quarter and full-year 2024 conference call. At the request of the company, this call is being recorded.
The entire contents of the call, including the presentation and question-and-answer session that will follow, are the copyrighted property of Quest Diagnostics with all rights reserved. Any redistribution, retransmission or rebroadcast of this call in any form without the written consent of Quest Diagnostics is strictly prohibited.
I'd now like to introduce Shawn Bevec, Vice President of Investor Relations for Quest Diagnostics. Sir, please go ahead.
Thank you, and good morning. I'm joined by Jim Davis, our Chairman, Chief Executive Officer and President; and Sam Samad, our Chief Financial Officer.
During this call, we may make forward-looking statements and will discuss non-GAAP measures. We provide a reconciliation of non-GAAP measures to comparable GAAP measures in the tables to our earnings press release. Actual
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
